FKBP family proteins as promising new biomarkers for cancer

Current Opinion in Pharmacology

Volumn 11, Issue 4, 2011, Pages 320-325

  Solassol, Jérôme ^a,b,c   Mange, Alain ^a,b,c   Maudelonde, Thierry ^a,b,c  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b CENTRE VAL D AURELLE   (France)

^c UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ARABINOSIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 12; FK 506 BINDING PROTEIN 38; FK 506 BINDING PROTEIN 51; FK 506 BINDING PROTEIN 52; FK 506 BINDING PROTEIN 65; GEMCITABINE; HEAT SHOCK PROTEIN 90; HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRINOTECAN; TAXANE DERIVATIVE; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER RESISTANCE; CARCINOGENESIS; COLORECTAL CANCER; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; NEOPLASM; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIOSENSITIVITY;

EID: 80051616394     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.03.012     Document Type: Review

References (47)

1. M.W. Harding, A. Galat, D.E. Uehling, and S.L. Schreiber A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase Nature 341 1989 758 760 (Pubitemid 19260893)
2. J.J. Siekierka, S.H. Hung, M. Poe, C.S. Lin, and N.H. Sigal A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin Nature 341 1989 755 757 (Pubitemid 19260892)
3. C. Schiene, and G. Fischer Enzymes that catalyse the restructuring of proteins Curr Opin Struct Biol 10 2000 40 45 (Pubitemid 30099325)
4. J. Liu, J.D. Farmer Jr., W.S. Lane, J. Friedman, I. Weissman, and S.L. Schreiber Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes Cell 66 1991 807 815 (Pubitemid 121001714)
5. R.A. Aldape, O. Futer, M.T. DeCenzo, B.P. Jarrett, M.A. Murcko, and D.J. Livingston Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex J Biol Chem 267 1992 16029 16032
6. V.K. Sharma, B. Li, A. Khanna, P.K. Sehajpal, and M. Suthanthiran Which way for drug-mediated immunosuppression? Curr Opin Immunol 6 1994 784 790 (Pubitemid 24312149)
7. Y.G. Chen, F. Liu, and J. Massague Mechanism of TGFbeta receptor inhibition by FKBP12 EMBO J 16 1997 3866 3876 (Pubitemid 27281003)
8. T. Wang, B.Y. Li, P.D. Danielson, P.C. Shah, S. Rockwell, R.J. Lechleider, J. Martin, T. Manganaro, and P.K. Donahoe The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors Cell 86 1996 435 444 (Pubitemid 26272083)
9. M. Lopez-Ilasaca, C. Schiene, G. Kullertz, T. Tradler, G. Fischer, and R. Wetzker Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor J Biol Chem 273 1998 9430 9434 (Pubitemid 28183024)
10. J.P. Higgins, K. Montgomery, L. Wang, E. Domanay, R.A. Warnke, J.D. Brooks, and M. van de Rijn Expression of FKBP12 in benign and malignant vascular endothelium: an immunohistochemical study on conventional sections and tissue microarrays Am J Surg Pathol 27 2003 58 64 (Pubitemid 36014899)
11. S. Khatua, K.M. Peterson, K.M. Brown, C. Lawlor, M.R. Santi, B. LaFleur, D. Dressman, D.A. Stephan, and T.J. MacDonald Overexpression of the EGFR/FKBP12/HIF-2alpha pathway identified in childhood astrocytomas by angiogenesis gene profiling Cancer Res 63 2003 1865 1870 (Pubitemid 36460850)
12. X. Bai, D. Ma, A. Liu, X. Shen, Q.J. Wang, Y. Liu, and Y. Jiang Rheb activates mTOR by antagonizing its endogenous inhibitor, FKBP38 Science 318 2007 977 980 (Pubitemid 350098994)
13. D. Ma, X. Bai, H. Zou, Y. Lai, and Y. Jiang Rheb GTPase controls apoptosis by regulating interaction of FKBP38 with Bcl-2 and Bcl-XL J Biol Chem 285 2010 8621 8627
14. F. Erdmann, F. Jarczowski, M. Weiwad, G. Fischer, and F. Edlich Hsp90-mediated inhibition of FKBP38 regulates apoptosis in neuroblastoma cells FEBS Lett 581 2007 5709 5714 (Pubitemid 350182414)
15. E. Lam, M. Martin, and G. Wiederrecht Isolation of a cDNA encoding a novel human FK506-binding protein homolog containing leucine zipper and tetratricopeptide repeat motifs Gene 160 1995 297 302
16. K.M. Pedersen, B. Finsen, J.E. Celis, and N.A. Jensen muFKBP38: a novel murine immunophilin homolog differentially expressed in Schwannoma cells and central nervous system neurons in vivo Electrophoresis 20 1999 249 255 (Pubitemid 29125010)
17. M. Kashani-Sabet, Y. Liu, S. Fong, P.Y. Desprez, S. Liu, G. Tu, M. Nosrati, C. Handumrongkul, D. Liggitt, and A.D. Thor Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice Proc Natl Acad Sci USA 99 2002 3878 3883 (Pubitemid 34252199)
18. D.L. Riggs, P.J. Roberts, S.C. Chirillo, J. Cheung-Flynn, V. Prapapanich, T. Ratajczak, R. Gaber, D. Picard, and D.F. Smith The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo EMBO J 22 2003 1158 1167 (Pubitemid 36313599)
19. J. Cheung-Flynn, V. Prapapanich, M.B. Cox, D.L. Riggs, C. Suarez-Quian, and D.F. Smith Physiological role for the cochaperone FKBP52 in androgen receptor signaling Mol Endocrinol 19 2005 1654 1666 (Pubitemid 41002993)
20. S. Tranguch, J. Cheung-Flynn, T. Daikoku, V. Prapapanich, M.B. Cox, H. Xie, H. Wang, S.K. Das, D.F. Smith, and S.K. Dey Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation Proc Natl Acad Sci USA 102 2005 14326 14331 (Pubitemid 41429697)
21. D.A. Peattie, M.W. Harding, M.A. Fleming, M.T. DeCenzo, J.A. Lippke, D.J. Livingston, and M. Benasutti Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes Proc Natl Acad Sci USA 89 1992 10974 10978
22. C. Desmetz, C. Bascoul-Mollevi, P. Rochaix, P.J. Lamy, A. Kramar, P. Rouanet, T. Maudelonde, A. Mange, and J. Solassol Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women Clin Cancer Res 15 2009 4733 4741
23. B.K. Ward, P.J. Mark, D.M. Ingram, R.F. Minchin, and T. Ratajczak Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer Breast Cancer Res Treat 58 1999 267 280 (Pubitemid 30113878)
24. P. Kumar, P.J. Mark, B.K. Ward, R.F. Minchin, and T. Ratajczak Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF-7 breast cancer cells Biochem Biophys Res Commun 284 2001 219 225 (Pubitemid 32924330)
25. S. Periyasamy, M. Warrier, M.P. Tillekeratne, W. Shou, and E.R. Sanchez The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms Endocrinology 148 2007 4716 4726 (Pubitemid 47481542)
26. J.F. Lin, J. Xu, H.Y. Tian, X. Gao, Q.X. Chen, Q. Gu, G.J. Xu, J.D. Song, and F.K. Zhao Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis Int J Cancer 121 2007 2596 2605 (Pubitemid 350136401)
27. Y. Liu, C. Li, Z. Xing, X. Yuan, Y. Wu, M. Xu, K. Tu, Q. Li, C. Wu, and M. Zhao Proteomic mining in the dysplastic liver of WHV/c-myc mice - insights and indicators for early hepatocarcinogenesis FEBS J 277 2010 4039 4053
28. U. Krummrei, E.E. Baulieu, and B. Chambraud The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis Proc Natl Acad Sci USA 100 2003 2444 2449 (Pubitemid 36297518)
29. B. Chambraud, C. Radanyi, J.H. Camonis, K. Shazand, K. Rajkowski, and E.E. Baulieu FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin J Biol Chem 271 1996 32923 32929
30. G. Baughman, G.J. Wiederrecht, F. Chang, M.M. Martin, and S. Bourgeois Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition Biochem Biophys Res Commun 232 1997 437 443 (Pubitemid 27216235)
31. W. Jiang, S. Cazacu, C. Xiang, J.C. Zenklusen, H.A. Fine, M. Berens, B. Armstrong, C. Brodie, and T. Mikkelsen FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway Neoplasia 10 2008 235 243 (Pubitemid 351337518)
32. H. Mukaide, Y. Adachi, S. Taketani, M. Iwasaki, N. Koike-Kiriyama, A. Shigematsu, M. Shi, S. Yanai, K. Yoshioka, and Y. Kamiyama FKBP51 expressed by both normal epithelial cells and adenocarcinoma of colon suppresses proliferation of colorectal adenocarcinoma Cancer Invest 26 2008 385 390 (Pubitemid 351601395)
33. E.T. Tatro, I.P. Everall, E. Masliah, B.J. Hult, G. Lucero, G. Chana, V. Soontornniyomkij, and C.L. Achim Differential expression of immunophilins FKBP51 and FKBP52 in the frontal cortex of HIV-infected patients with major depressive disorder J Neuroimmune Pharmacol 4 2009 218 226
34. S. Periyasamy, T. Hinds Jr., L. Shemshedini, W. Shou, and E.R. Sanchez FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A Oncogene 29 2009 1691 1701
35. A.M. Velasco, K.A. Gillis, Y. Li, E.L. Brown, T.M. Sadler, M. Achilleos, L.M. Greenberger, P. Frost, W. Bai, and Y. Zhang Identification and validation of novel androgen-regulated genes in prostate cancer Endocrinology 145 2004 3913 3924 (Pubitemid 39037580)
36. P.G. Febbo, M. Lowenberg, A.R. Thorner, M. Brown, M. Loda, and T.R. Golub Androgen mediated regulation and functional implications of fkbp51 expression in prostate cancer J Urol 173 2005 1772 1777 (Pubitemid 40524830)
37. G. Baughman, G.J. Wiederrecht, N.F. Campbell, M.M. Martin, and S. Bourgeois FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition Mol Cell Biol 15 1995 4395 4402
38. M.F. Romano, R. Avellino, A. Petrella, R. Bisogni, S. Romano, and S. Venuta Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells Eur J Cancer 40 2004 2829 2836 (Pubitemid 39574738)
39. H. Pei, L. Li, B.L. Fridley, G.D. Jenkins, K.R. Kalari, W. Lingle, G. Petersen, Z. Lou, and L. Wang FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt Cancer Cell 16 2009 259 266
40. L. Ni, C.S. Yang, D. Gioeli, H. Frierson, D.O. Toft, and B.M. Paschal FKBP51 promotes assembly of the Hsp90 chaperone complex and regulates androgen receptor signaling in prostate cancer cells Mol Cell Biol 30 2010 1243 1253
41. S. Romano, A. D'Angelillo, R. Pacelli, S. Staibano, E. De Luna, R. Bisogni, E.L. Eskelinen, M. Mascolo, G. Cali, and C. Arra Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells Cell Death Differ 17 2009 145 157
42. T. Bouwmeester, A. Bauch, H. Ruffner, P.O. Angrand, G. Bergamini, K. Croughton, C. Cruciat, D. Eberhard, J. Gagneur, and S. Ghidelli A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway Nat Cell Biol 6 2004 97 105 (Pubitemid 38425708)
43. G.E. Johnson, V.N. Ivanov, and T.K. Hei Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival Apoptosis 13 2008 790 802
44. A. Munshi, J.F. Kurland, T. Nishikawa, P.J. Chiao, M. Andreeff, and R.E. Meyn Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells Mol Cancer Ther 3 2004 985 992 (Pubitemid 39199593)
45. M.C. Coss, R.M. Stephens, D.K. Morrison, D. Winterstein, L.M. Smith, and S.L. Simek The immunophilin FKBP65 forms an association with the serine/threonine kinase c-Raf-1 Cell Growth Differ 9 1998 41 48 (Pubitemid 28049526)
46. S.H. Olesen, L.L. Christensen, F.B. Sorensen, T. Cabezon, S. Laurberg, T.F. Orntoft, and K. Birkenkamp-Demtroder Human FK506 binding protein 65 is associated with colorectal cancer Mol Cell Proteomics 4 2005 534 544 (Pubitemid 40590570)
47. G. Kullertz, S. Luthe, and G. Fischer Semiautomated microtiter plate assay for monitoring peptidylprolyl cis/trans isomerase activity in normal and pathological human sera Clin Chem 44 1998 502 508 (Pubitemid 28141344)